Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04582370 · ClinicalTrials.gov registry record · NA

Impact of Theater Experience on Older Adults Living in Retirement Communities

A NA study, sponsored by University of Alabama at Birmingham.

Completed
Registry status
NA
Development phase
84
Enrollment target

NCT04582370 is a NA study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 84 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04582370, a NA study, has completed, sponsored by University of Alabama at Birmingham.

COMPLETED
Registry status
NA
Development phase
84 participants
Enrollment target

Study Summary

Theater is a complex, multi-component performing art. On stage, actors not only need to memorize the script, but also be able to portray emotion and feeling through movement and move in whichever manner is deemed appropriate by the script. Acting therefore requires as much movement as it does vocalization. As training exercises in theater naturally involve boosting physical, cognitive and affective function, and social relationships, theater experience can be used to promote health and wellness. Over the last two decades, there has been an increase in the use of theater to promote health and wellness among older adults. Thus, the overall aim of this project is to evaluate the therapeutic benefits of a 10-week theory-based theater program on physical functioning and emotional stress among older adults. Hypothesis #1: Older adults residing in subsidized housing who participate in a theory-based theater program will demonstrate better physical functioning, and reduction in emotional stress than wait-list controls at the conclusion of a 10-week theater program. Hypothesis #2: The positive impact of the theater program on the residents' improved physical functioning and stress level will be maintained at 3-month follow-up.

Interventions

  • BEHAVIORAL theater program

Trial Details

FieldValue
Enrollment Target 84 participants
Start Date 2021-10-04
Est. Completion 2023-04-17
Phase NA

Sponsor

University of Alabama at Birmingham

1,160 total trials

What the Registry Record Tells You About NCT04582370

The ClinicalTrials.gov registry entry for NCT04582370 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 84 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which theater program is the first listed.

NCT04582370 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04582370 about?

NCT04582370 is a clinical study titled "Impact of Theater Experience on Older Adults Living in Retirement Communities". Theater is a complex, multi-component performing art. On stage, actors not only need to memorize the script, but also be able to portray emotion and feeling through movement and move in whichever manner is deemed appropriate by the script. Acting therefore requires as much movement as it does vocali...

What is the current status of trial NCT04582370?

This trial is currently completed. It is a NA study. The enrollment target is 84 participants. The study started on 2021-10-04. Estimated completion is 2023-04-17.

What interventions are being tested in trial NCT04582370?

The interventions under investigation include: theater program (BEHAVIORAL).

Who is sponsoring clinical trial NCT04582370?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.